These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26330357)

  • 1. Evaluation of p40 as a Myoepithelial Marker in Different Breast Lesions.
    Kővári B; Szász AM; Kulka J; Marušić Z; Šarčević B; Tiszlavicz L; Cserni G
    Pathobiology; 2015 Sep; 82(3-4):166-71. PubMed ID: 26330357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P40 Immunostain Does Not Outperform p63 as a Myoepithelial Cell Marker in the Daily Practice of Breast Pathology.
    Khazai L; Agosto-Arroyo E; Rosa M
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):599-604. PubMed ID: 28549030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostaining of ∆Np63 (using the p40 antibody) is equal to that of p63 and CK5/6 in high-grade ductal carcinoma in situ of the breast.
    Sailer V; Lüders C; Kuhn W; Pelzer V; Kristiansen G
    Virchows Arch; 2015 Jul; 467(1):67-70. PubMed ID: 25850754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers.
    Collins LC; Carlo VP; Hwang H; Barry TS; Gown AM; Schnitt SJ
    Am J Surg Pathol; 2006 Aug; 30(8):1002-7. PubMed ID: 16861972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p63 expression in benign and malignant breast lesions.
    Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
    Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast.
    Tse GM; Tan PH; Lui PC; Gilks CB; Poon CS; Ma TK; Law BK; Lam WW
    J Clin Pathol; 2007 Mar; 60(3):315-20. PubMed ID: 16698948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.
    Pavlakis K; Zoubouli C; Liakakos T; Messini I; Keramopoullos A; Athanassiadou S; Kafousi M; Stathopoulos EN
    Breast; 2006 Dec; 15(6):705-12. PubMed ID: 16384708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.
    Ren S; Abuel-Haija M; Khurana JS; Zhang X
    Int J Clin Exp Pathol; 2011 Jan; 4(2):175-82. PubMed ID: 21326813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
    Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
    Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic and immunohistochemical study of 187 cases of intraductal papillary neoplasm of breast].
    Zhang H; Xiong Y; Zhang S; Zhang Y; Wang YH; Li T
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):726-31. PubMed ID: 22336153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cytokeratin phenotypes of myoepithelial cells indicates the origin of ductal carcinomas in situ of the breast.
    Chen L; Yin X; Lu S; Chen G; Dong L
    Appl Immunohistochem Mol Morphol; 2015 Sep; 23(8):558-64. PubMed ID: 26336082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic role of DOG1 and p63 immunohistochemistry in salivary gland carcinomas.
    Abd Raboh NM; Hakim SA
    Int J Clin Exp Pathol; 2015; 8(8):9214-22. PubMed ID: 26464669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumours.
    D'Alfonso TM; Ross DS; Liu YF; Shin SJ
    J Clin Pathol; 2015 Jul; 68(7):516-21. PubMed ID: 25795733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratin Expression Patterns in Stromal Cells of Benign Sclerosing Lesions of the Breast: A Potential Diagnostic Pitfall.
    Oh EY; Collins LC
    Arch Pathol Lab Med; 2015 Sep; 139(9):1143-8. PubMed ID: 25989286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p40 (ΔNp63) expression in breast disease and its correlation with p63 immunohistochemistry.
    Kim SK; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(3):1032-41. PubMed ID: 24696720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
    Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
    Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of p63/p40 Expression With Myoepithelial Markers in Minor Salivary Gland Tumors.
    Teixeira LN; Janner ÉC; Teixeira T; Passador-Santos F; Martinez EF; Demasi APD; de Araújo NS; de Araújo VC
    Int J Surg Pathol; 2019 Jun; 27(4):360-371. PubMed ID: 30482064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of myoepithelial markers in adenomyoepithelioma of the breast: a unique paradoxical staining pattern of high-molecular weight cytokeratins.
    Moritani S; Ichihara S; Yatabe Y; Hasegawa M; Iwakoshi A; Hosoda W; Narita M; Nagai Y; Asai M; Ujihira N; Yuba Y; Jijiwa M
    Virchows Arch; 2015 Feb; 466(2):191-8. PubMed ID: 25479938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of p63 and CK5/6 expression in the differential diagnosis of ductal lesions of breast.
    Ding Y; Ruan Q
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):405-7. PubMed ID: 17120733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.